Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Intracranial pressure increased? 67 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Intracranial pressure increased have been filed in association with RISPERIDONE (Risperidone). This represents 0.1% of all adverse event reports for RISPERIDONE.

67
Reports of Intracranial pressure increased with RISPERIDONE
0.1%
of all RISPERIDONE reports
0
Deaths
42
Hospitalizations

How Dangerous Is Intracranial pressure increased From RISPERIDONE?

Of the 67 reports, 42 (62.7%) required hospitalization, and 1 (1.5%) were considered life-threatening.

Is Intracranial pressure increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 67 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Intracranial pressure increased?

LEVONORGESTREL (195) SOMATROPIN (150) METHOTREXATE (140) PREDNISONE (127) ACETAMINOPHEN (123) TACROLIMUS (104) ADALIMUMAB (99) DOXYCYCLINE (94) CYCLOSPORINE (91) MYCOPHENOLATE MOFETIL (80)

Which RISPERIDONE Alternatives Have Lower Intracranial pressure increased Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Intracranial pressure increased Reports All Drugs Causing Intracranial pressure increased RISPERIDONE Demographics